Adam Gilden, MD, MSCE Medical Reviewer Adam Gilden, MD, MSCE, is an associate director of the Obesity Medicine Fellowship at University of Colorado School of Medicine and associate director of the Colorado University Me
For Japanese companies or those with non-December fiscal year endings, revenue has been calculated for the JanuaryDecember period using their quarterly filings
At the same time, pharmaceutical companies are putting serious money into R and D, trying to bring in next-generation therapies and make results more consistent for patients
By distribution channel analysis In 2024, the hospital pharmacies segment led the global GLP-1 receptor agonist market
This synergistic interaction enhances overall insulinotropic and glucoregulatory efficacy, positioning tirzepatide as a first-in-class dual incretin receptor agonist with superior metabolic outcomes